Phase IV Multi-arm Study of CDK4/6 Pharmacokinetics in Healthy Volunteers With Known CYP3A4*22 Genotype
Clinical trial NCT05691400 · WITHDRAWN
Trial details
- NCT number
- NCT05691400
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-01
- Primary completion
- 2027-03-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.